Operant Conditioning After ACL Reconstruction

January 22, 2024 updated by: Riann Palmieri-Smith, University of Michigan

Conditioning Brain Responses for Modulating Corticospinal Excitability After ACL Reconstruction

The purpose of this study is to examine if the changes in corticospinal function that accompany ACL reconstruction can be improved through a form of mental coaching and encouragement, known as operant conditioning.

Study Overview

Detailed Description

It is theorized reduced corticospinal excitability contributes to quadriceps dysfunction after knee injury and joint disease. Current rehabilitation does not directly target the alterations in corticospinal excitability, which may limit recovery. Operant conditioning is an emerging approach capable of increasing corticospinal excitability by directly targeting the corticospinal pathways. However, it remains to be determined whether operant conditioning of the corticospinal pathway may improve corticospinal function after knee trauma. Therefore, this study will evaluate the ability of operant up-conditioning of the corticospinal pathway to improve corticospinal function after ACL reconstruction.

Study Type

Interventional

Enrollment (Actual)

22

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Michigan
      • Ann Arbor, Michigan, United States, 48109
        • University of Michigan

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years to 45 years (Child, Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • aged 14-45 years
  • suffered an acute, complete ACL rupture
  • have undergone ACL reconstructive surgery
  • willingness to participate in testing and follow-up as outlined in the protocol

Exclusion Criteria:

  • have suffered a previous ACL injury on the contralateral leg
  • have undergone previous major surgery to the contralateral knee
  • have a history of recent significant knee injury (other than ACL) or lower-extremity fracture
  • have a history of uncontrolled diabetes or hypertension
  • be pregnant or plan to become pregnant
  • have metal implants in the head
  • have electronic devices in their ear or heart (e.g., cochlear implants or cardiac pacemakers)
  • have unexplained recurrent headaches
  • have a recent history of seizure
  • have a history of repeated fainting spells

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Operant Conditioning
Motor evoked responses will be elicited along with operant conditioning training for about 2 weeks
Active encouragement and feedback to increase motor evoked response during stimulation.
Experimental: Control
Motor evoked responses will be elicited without operant conditioning training for about 2 weeks
Absence of active encouragement and feedback to increase motor evoked response when stimulated.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in corticospinal excitability
Time Frame: Baseline (before the start of the intervention) and post-intervention (approximately 2 weeks after baseline)
Corticospinal excitability will be measured using transcranial magnetic stimulation at baseline and post-intervention and will be compared between groups.
Baseline (before the start of the intervention) and post-intervention (approximately 2 weeks after baseline)

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in quadriceps strength
Time Frame: Baseline (before the start of the intervention) and post-intervention (approximately 2 weeks after baseline)
Isometric quadriceps strength will be measured using an isokinetic dynamometer. Quadriceps strength will be measured prior to the intervention and immediately following the intervention.
Baseline (before the start of the intervention) and post-intervention (approximately 2 weeks after baseline)
Changes in quadriceps voluntary activation
Time Frame: Baseline (before the start of the intervention) and post-intervention (approximately 2 weeks after baseline)
Voluntary activation will be measured using an electrical superimposition technique. Voluntary activation will be measured prior to the intervention and immediately following the intervention.
Baseline (before the start of the intervention) and post-intervention (approximately 2 weeks after baseline)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 28, 2022

Primary Completion (Actual)

October 10, 2023

Study Completion (Actual)

October 10, 2023

Study Registration Dates

First Submitted

August 17, 2022

First Submitted That Met QC Criteria

August 26, 2022

First Posted (Actual)

August 29, 2022

Study Record Updates

Last Update Posted (Estimated)

January 23, 2024

Last Update Submitted That Met QC Criteria

January 22, 2024

Last Verified

January 1, 2024

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • HUM00166442

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anterior Cruciate Ligament Injuries

Clinical Trials on Operant Conditioning

Subscribe